Ignite Creation Date:
2024-05-05 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00562068
Status:
UNKNOWN
Last Update Posted:
2013-08-26
First Post:
2007-11-20
Brief Title:
Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I Stage II Stage III or Stage IV Peripheral T-Cell Lymphoma
Sponsor:
Cancer Research UK
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Small Intestine Cancer |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| peripheral T-cell lymphoma | View |
| recurrent adult T-cell leukemialymphoma | View |
| stage I adult T-cell leukemialymphoma | View |
| stage II adult T-cell leukemialymphoma | View |
| stage III adult T-cell leukemialymphoma | View |
| stage IV adult T-cell leukemialymphoma | View |
| anaplastic large cell lymphoma | View |
| angioimmunoblastic T-cell lymphoma | View |
| small intestine lymphoma | View |